Joel A. Pearlman, MD, PhD
Show Description +
Dr. Pearlman summarizes the positive results from a phase 2a study of RZ402 (Rezolute), an orally administered plasma kallikrein inhibitor to treat diabetic macular edema.
Posted: 10/22/2024
Joel A. Pearlman, MD, PhD
Dr. Pearlman summarizes the positive results from a phase 2a study of RZ402 (Rezolute), an orally administered plasma kallikrein inhibitor to treat diabetic macular edema.
Posted: 10/22/2024
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2024.
Please log in to leave a comment.